ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

NUWE Newellis Inc

0.1705
-0.0355 (-17.23%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Newellis Inc NUWE 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.0355 -17.23% 0.1705 13:00:08
개장가 저가 고가 종가 전일 종가
0.215 0.1674 0.232 0.18 0.206
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202422:00GLOBENuwellis Receives USPTO Notice of Patent Allowance for..
01/05/202407:09GLOBENuwellis Announces Closing of $2.7 Million Public Offering
01/05/202405:41GLOBENuwellis, Inc. To Report First Quarter 2024 Financial..
26/04/202422:17GLOBENuwellis Announces Pricing of $2.7 Million Public Offering
09/04/202422:00GLOBENuwellis Announces Launch of Ultrafiltration Therapy Using..
12/03/202406:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/03/202423:08GLOBELate-Breaking Data Highlighting Benefits of Ultrafiltration..
07/03/202402:02EDGAR2Form 8-K - Current report
05/03/202422:00GLOBENuwellis, Inc. Announces Fourth Quarter and Full Year 2023..
05/03/202420:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
27/02/202423:00GLOBENuwellis, Inc. To Report Fourth Quarter and Full Year 2023..
22/02/202421:58GLOBENuwellis’ Distribution Partner, SeaStar Medical, Receives..
21/02/202407:06GLOBENuwellis, Inc. Reports Inducement Grants Under Nasdaq..
20/02/202422:42GLOBENuwellis to Announce Late-Breaking Clinical Data and Host..
09/02/202407:19EDGAR2Form S-1/A - General form for registration of securities..
06/02/202423:07EDGAR2Form 8-K - Current report
06/02/202423:00GLOBENew Case Series Demonstrates Potential of Aquadex Therapy..
10/01/202407:30EDGAR2Form 8-K/A - Current report: [Amend]
08/01/202423:24EDGAR2Form 8-K - Current report
05/01/202406:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202405:05GLOBENuwellis Receives FDA Clearance for an Additional Dual Lumen..
14/12/202306:05EDGAR2Form 8-K - Current report
28/11/202322:00GLOBENew Real-World Data Highlight the Clinical Benefits of..
15/11/202306:30GLOBENuwellis, Inc. Reports Inducement Grants Under Nasdaq..
08/11/202300:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:15EDGAR2Form 8-K - Current report
07/11/202322:00GLOBENuwellis, Inc. Announces Third Quarter 2023 Financial..
02/11/202305:15EDGAR2Form 8-K - Current report
01/11/202321:00GLOBENuwellis Announces Board of Directors Transition
31/10/202321:00GLOBENuwellis’ Strategic Partner, SeaStar Medical, Receives FDA..
19/10/202305:15GLOBENuwellis, Inc. To Announce Third Quarter 2023 Financial..
18/10/202305:30EDGAR2Form 8-K - Current report
18/10/202305:15GLOBENuwellis Announces Closing of $2.25 Million Public Offering..
13/10/202321:30GLOBENuwellis Announces Pricing of $2.25 Million Public Offering..
10/10/202321:30EDGAR2Form 8-K - Current report
10/10/202321:00GLOBENuwellis Provides Regulatory Update on SeaStar Medical’s..
07/10/202305:50EDGAR2Form POS462C - Post-effective amendment to registration..
05/10/202322:27EDGAR2Form AW - Amendment Withdrawal Request
05/10/202306:29EDGAR2Form POS AM - Post-Effective amendments for registration..
02/10/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
29/09/202321:56EDGAR2Form S-1/A - General form for registration of securities..
12/09/202305:15GLOBENuwellis to Present at the Gilmartin Group Emerging Growth..
07/09/202305:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/09/202305:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/08/202305:56EDGAR2Form 8-K - Current report
09/08/202301:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202321:25EDGAR2Form 8-K - Current report
08/08/202321:15EDGAR2Form 8-K - Current report
08/08/202321:15GLOBENuwellis, Inc. Announces Second Quarter 2023 Financial..
08/08/202321:00GLOBENuwellis Announces Plan for CFO Transition

최근 히스토리

Delayed Upgrade Clock